Typ-1-Diabetes bei Kindern: Bessere glykämische Kontrolle durch Hybrid -Closed-Loop-System
Hybrid closed loop to be recommended for over 100,000 people with type 1 diabetes - JDRF, the type 1 diabetes charity
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study - The Lancet Diabetes & Endocrinology
PDF) Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors
IJMS | Free Full-Text | Maturity Onset Diabetes of the Young—New Approaches for Disease Modelling
The Engineer - Hybrid closed loop system seen as step toward artificial pancreas
Hybrid closed-loop insulin delivery systems for Type 1 diabetes come of age | News Center | Stanford Medicine
Double or Hybrid Diabetes JDC monthly diabetes newsletter. Issue 133 November 2019
Hybrid closed-loop system poses no increased burden for children with type 1 diabetes
Hybrid Diabetes screening camp by Ladies Club - Stories of Pride
Suboptimal kontrollierter Typ-1-Diabetes: Hybrid-Closed-Loop-System reduziert vor allem das Risiko für Hypoglykämien
Hybrid-Pressekonferenz der Deutschen Diabetes Gesellschaft (DDG): Deutsche Diabetes Gesellschaft e.V.
Hybrid-Closed-Loop: Was die neue halbautomatische Insulinpumpe kann | Apotheken Umschau
Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors | Nutrition & Diabetes
Advanced-Hybrid-Closed-Loop System | Medtronic Diabetes DE
Diabetes-Technologie - Hybrid Closed Loop – das Ende des Pumpenplans?
A Hybrid Closed-Loop Insulin Delivery System for the Treatment of Type 1 Diabetes - CADTH Issues in Emerging Health Technologies - NCBI Bookshelf
Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors | Nutrition & Diabetes
First official 'hybrid closed-loop' insulin system for type 1 diabetes in UK
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial - The Lancet
Life Science Meeting zu „Neue Wirkstoffe zur Behandlung von Diabetes“ – LifeScienceNet